Treatment of Clostridium difficile Infection with a Small-Molecule Inhibitor of Toxin UDP-Glucose Hydrolysis Activity

Antimicrobial Agents and Chemotherapy
Ilana L StrokeDavid W Hilbert

Abstract

Clostridium difficile infection (CDI) is the leading cause of hospital-acquired infectious diarrhea, with significant morbidity, mortality, and associated health care costs. The major risk factor for CDI is antimicrobial therapy, which disrupts the normal gut microbiota and allows C. difficile to flourish. Treatment of CDI with antimicrobials is generally effective in the short term, but recurrent infections are frequent and problematic, indicating that improved treatment options are necessary. Symptoms of disease are largely due to two homologous toxins, TcdA and TcdB, which are glucosyltransferases that inhibit host Rho GTPases. As the normal gut microbiota is an important component of resistance to CDI, our goal was to develop an effective nonantimicrobial therapy. Here, we report a highly potent small-molecule inhibitor (VB-82252) of TcdA and TcdB. This compound inhibits the UDP-glucose hydrolysis activity of TcdB and protects cells from intoxication after challenge with either toxin. Oral dosing of the inhibitor prevented inflammation in a murine intrarectal toxin challenge model. In a murine model of recurrent CDI, the inhibitor reduced weight loss and gut inflammation during acute disease and did not cause the recurrent ...Continue Reading

References

May 24, 2001·The Journal of Infectious Diseases·S P SambolD N Gerding
Apr 16, 2005·Clinical Microbiology Reviews·Daniel E Voth, Jimmy D Ballard
Mar 6, 2007·Nature·Jessica ReinekeChristoph von Eichel-Streiber
Jan 18, 2008·The Journal of Infectious Diseases·Ju Young ChangVincent B Young
Apr 9, 2008·Trends in Microbiology·Thomas Jank, Klaus Aktories
Oct 14, 2008·Gastroenterology·Xinhua ChenCiarán P Kelly
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Simon D BainesMark H Wilcox
Jun 17, 2009·Nature Reviews. Microbiology·Maja RupnikDale N Gerding
Jun 26, 2009·The Journal of Biological Chemistry·Rory N PruittD Borden Lacy
May 12, 2010·Nucleic Acids Research·Liisa Holm, Päivi Rosenström
Feb 4, 2011·The New England Journal of Medicine·Thomas J LouieUNKNOWN OPT-80-003 Clinical Study Group
Feb 15, 2011·Nature Structural & Molecular Biology·Aimee ShenMatthew Bogyo
Aug 23, 2011·Nature Medicine·Tor C SavidgeCharalabos Pothoulakis
May 5, 2012·Gut Microbes·Emma L BestMark H Wilcox
May 1, 2013·Microbiology·Robert G K DonaldAnnaliesa S Anderson
Dec 4, 2013·Microbiology and Molecular Biology Reviews : MMBR·Jonathan J Hunt, Jimmy D Ballard
Nov 19, 2014·Infection and Immunity·Shan LiHanping Feng
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
Sep 25, 2015·Science Translational Medicine·Kristina Oresic BenderMatthew Bogyo
Oct 27, 2016·Current Opinion in Infectious Diseases·Jessica Martin, Mark Wilcox
Jan 26, 2017·The New England Journal of Medicine·Mark H WilcoxUNKNOWN MODIFY I and MODIFY II Investigators
Jan 15, 2018·Bioorganic & Medicinal Chemistry Letters·Jeffrey J LetourneauMaria L Webb

❮ Previous
Next ❯

Citations

Aug 23, 2019·Medicinal Research Reviews·Catherine H Schein
Mar 19, 2021·ACS Infectious Diseases·Carly DeusenberyAnita Shukla
Nov 28, 2021·Nature Reviews. Microbiology·Shannon L KordusD Borden Lacy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Investigation
Sarah S Lewis, Deverick J Anderson
Infectious Disease Clinics of North America
Jennie H KwonErik R Dubberke
Frontiers in Cellular and Infection Microbiology
Rory N Pruitt, D Borden Lacy
Critical Reviews in Microbiology
Melina KachrimanidouNikolaos Malisiovas
© 2022 Meta ULC. All rights reserved